You are here:Home-Chemical Inhibitors & Agonists-Cell Cycle/DNA Damage-LIM Kinase (LIMK)-R-10015
R-10015

Chemical Structure : R-10015

CAS No.: 2097938-51-5

R-10015 (R 10015;R10015)

Catalog No.: PC-60271Not For Human Use, Lab Use Only.

R-10015 (R10015) is a potent, selective inhibitor of human LIMK1 with IC50 of 38 nM.

Packing Price Stock Quantity
5 mg $128 In stock
10 mg $198 In stock
25 mg $328 In stock
50 mg Get quote
100 mg Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC) Select Batch:

Biological Activity

R-10015 (R10015) is a potent, selective inhibitor of human LIMK1 with IC50 of 38 nM.
R-10015 exhibits good selectivity, with off-target inhibition of only LRRK2 and p70S6K (≥90% inhibition at 1 uM) and moderate inhibition of PKA (76%), ROCK2 (70%), and FLT3 (68%).
R-10015 blocks HIV-1 viral DNA synthesis, nuclear migration, and virion release.
R-10015 has broad-spectrum antiviral effect and inhibits multiple viruses, including EBOV, RVFV, VEEV, and HSV-1.

Physicochemical Properties

M.Wt 410.86
Formula C20H19ClN6O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20 °C 12 Months; 4°C 6 Months
In Solvent
-80 °C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

Methyl 2-(1-(5-chloro-7H-pyrrolo[2,3-d]pyrimidin-4-yl) piperidin-4-yl)-1H-benzo[d]imidazole-5-carboxylate

References

1. Yi F, et al. J Virol. 2017 Jun 9;91(13). pii: e02418-16.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: